Tag Archives: COKE

Hot Low Price Stocks To Buy For 2018

An extended bout of low prices and tepid wage growth are showing signs of ending and that has government-bond investors bracing for a new inflation regime.

Rising inflation is anathema to bonds because it can erode the securitys fixed value, which is a notable headwind for longer-dated government paper.

Contributing to the anticipation of higher inflation are climbing commodity prices, improving global growth and lingering fears that tightening labor markets will eventually translate into higher wage gains. That has stoked fears that a pick up in what has otherwise been stubbornly low inflation will blindside Treasury buyers.

Hot Low Price Stocks To Buy For 2018: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Synovus Financial Corp bought a new position in shares of Veeva Systems (NYSE:VEEV) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,741 shares of the technology company’s stock, valued at approximately $201,000.

  • [By Kristine Harjes]

    In this week’s episode of Industry Focus: Healthcare, host Kristine Harjes interviews Matt Wallach, the co-founder and president of cloud computing companyVeeva Systems(NYSE:VEEV). Veeva serves healthcare companies across the board, from fledgling biotechs to massive stalwarts like Johnson & Johnson, and many investors see big potential for sustainable, long-term growth in the future.

  • [By Motley Fool Staff]

    Matt Wallach is the co-founder and president of Veeva Systems(NYSE:VEEV), a cloud-based software company that found success catering to the life-sciences industry. But the company isn’t stopping there.

Hot Low Price Stocks To Buy For 2018: Cimpress N.V(CMPR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Cimpress alerts:

    Cimpress (CMPR) Earns Hold Rating from SunTrust Banks (americanbankingnews.com) Katryn Blake Sells 9,297 Shares of Cimpress (CMPR) Stock (americanbankingnews.com) Insider Selling: Cimpress (CMPR) CEO Sells 4,648 Shares of Stock (americanbankingnews.com) Cimpress’ (CMPR) “Sell” Rating Reiterated at Aegis (americanbankingnews.com) Cimpress (CMPR) Given Consensus Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of equities analysts recently weighed in on the company. SunTrust Banks reaffirmed a “hold” rating and issued a $144.00 price target on shares of Cimpress in a report on Tuesday. ValuEngine raised Cimpress from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. Aegis reaffirmed a “sell” rating and issued a $114.00 price target on shares of Cimpress in a report on Tuesday. BidaskClub cut Cimpress from a “buy” rating to a “hold” rating in a report on Friday, May 4th. Finally, Barrington Research reaffirmed a “buy” rating and issued a $165.00 price target on shares of Cimpress in a report on Tuesday, May 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $140.00.

  • [By Logan Wallace]

    SunTrust Banks reaffirmed their hold rating on shares of Cimpress (NASDAQ:CMPR) in a research note published on Tuesday. SunTrust Banks currently has a $144.00 price objective on the business services provider’s stock.

  • [By Steve Symington]

    Cimpress NV(NASDAQ:CMPR)announced fiscal third-quarter 2018 results on Wednesday after the market closed, detailing the continued fruits of last year’s Vistaprint restructuring and steady growth at each of its three core business segments.Still, shares of the mass customization specialist were down on Thursday in response to the news.

Hot Low Price Stocks To Buy For 2018: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Hot Low Price Stocks To Buy For 2018: Macatawa Bank Corporation(MCBC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Macatawa Bank (NASDAQ:MCBC) from a buy rating to a strong-buy rating in a research note released on Friday morning.

    Separately, Hovde Group set a $11.00 price target on Macatawa Bank and gave the stock a hold rating in a research report on Monday, January 29th.

Hot Low Price Stocks To Buy For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Constant advances in technology require companies of all sizes to make efforts to keep up and take maximum advantage of new capabilities before competitors do. That puts companies like EPAM Systems (NYSE:EPAM) in a great position, because the resulting demand for IT services is constant and growing. EPAM did a good job of fulfilling its potential for strong growth in 2017, and the IT services specialist has high hopes that 2018 will bring even more gains.

Hot Low Price Stocks To Buy For 2018: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin]

    Shares of Limelight Networks, Inc. (NASDAQ: LLNW) got a boost, shooting up 25 percent to $5.14 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
    Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
    New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
    Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
    Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
    Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
    Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
    Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
    Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford

  • [By Lisa Levin]

    Shares of Limelight Networks, Inc. (NASDAQ: LLNW) got a boost, shooting up 26 percent to $5.17 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Limelight Networks (LLNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks For 2018

Prabhudas Lilladher’s research report on Dabur India

Dabur has shown 7.7% domestic volume growth on a low base led by market share gains in most segments. Dabur is aiming for 8-10% volume growth in 1H19 which can increase to double digit in 2H19 depending upon monsoons. Gross margins are unlikely to expand, however better profitability in IBD and operating leverage in domestic business will provide moderate margin expansion. Dabur expects GST e-way bill led trade disruptions in 1Q however overall demand scenario looks optimistic.

Outlook

We estimate 16% PAT CAGR over FY18-20. We value Dabur at 35xFY20 EPS and arrive at target price of Rs377. We expect back ended returns post 32% upmove in last 1 year. Maintain “Accumulate”.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Hot Value Stocks For 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

Hot Value Stocks For 2018: Range Resources Corporation(RRC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) fell about 4.4% Tuesday to post a new 52-week low of $14.43 after closing at $15.09 on Monday. The 52-week high is $34.93. Volume of about 15 million was nearly double the daily average of around 7.7 million shares traded. The company had no specific news.

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) fell about 3.6% Monday to post a new 52-week low of $14.77 after closing at $15.30 on Friday. The 52-week high is $35.64. Volume of about 9.4 million was about 20% higher than the daily average of around 7.7 million shares traded. The company had no specific news.

Hot Value Stocks For 2018: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Top 5 China Stocks To Buy For 2019

President Donald Trump believes he's a great dealmaker… But is he?   His dealmaking with China looks amateurish…   "China's a currency manipulator!" he repeated relentlessly on the campaign trail – threatening the world's second-biggest country with sanctions.   He's wrong about this. Completely wrong. It shows his ignorance of global economics, and it makes the U.S. look bad.   Importantly, Trump finally conceded that China is not a currency manipulator this week – or at least that he won't call it one…   "Why would I call China a currency manipulator when they are working with us on the North Korean problem?" he Tweeted on Sunday.   But why did he call China a currency manipulator in the first place? Why would he keep repeating this lie for so long?  

Top 5 China Stocks To Buy For 2019: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

Top 5 China Stocks To Buy For 2019: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aclaris Therapeutics (NASDAQ:ACRS) has received a consensus recommendation of “Hold” from the eight research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $46.00.

  • [By Joseph Griffin]

    Aclaris Therapeutics (NASDAQ:ACRS) received a $50.00 price target from equities research analysts at Cantor Fitzgerald in a report issued on Tuesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 177.62% from the company’s current price.

Top 5 China Stocks To Buy For 2019: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By Chris Lange]

    Look for Tiffany & Co.’s (NYSE: TIF) fiscal fourth-quarter report on Friday. The consensus forecast is $1.64 in EPS on $1.31 billion in revenue. Shares last traded at $101.76. The consensus price target is $111.88, and shares have traded between $84.15 and $111.44 in the past 52 weeks.

  • [By ]

    HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

  • [By Shane Hupp]

    First Eagle Investment Management LLC trimmed its holdings in shares of Tiffany & Co. (NYSE:TIF) by 0.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,798,751 shares of the specialty retailer’s stock after selling 29,056 shares during the period. First Eagle Investment Management LLC owned 3.06% of Tiffany & Co. worth $370,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Tiffany & Co. (NYSE: TIF) which traded down 5% at $97.51. The stocks 52-week range is $84.15 to $111.44. Volume was 7.8 million compared to the daily average volume of 1.3 million.

Top 5 China Stocks To Buy For 2019: Avangrid, Inc.(AGR)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Avangrid Inc.(NYSE:AGR) Q1 2018 Earnings Conference CallApril 23, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Companies Reporting Before The Bell
    Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
    Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
    Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
    Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
    Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
    Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
    Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
    FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
    Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
    Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
    Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.

     

Top 5 China Stocks To Buy For 2019: News Corporation(NWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Hot High Tech Stocks To Buy For 2019

Jackson, WY, based Investment company Cannell Capital Llc buys Craft Brew Alliance Inc, Internap Corp, magicJack VocalTec, Limelight Networks Inc, Destination XL Group Inc, Health Insurance Innovations Inc, I.D. Systems Inc, TripAdvisor Inc, Liberty Tax Inc, Pure Storage Inc, sells Rightside Group, eHealth Inc, Blue Bird Corp, BioTelemetry Inc, Alliance HealthCare Services Inc during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Cannell Capital Llc. As of 2017-09-30, Cannell Capital Llc owns 60 stocks with a total value of $338 million. These are the details of the buys and sells.

New Purchases: CALL, DXLG, TRIP, MNTX, Added Positions: BREW, INAP, LLNW, HIIQ, IDSY, TAST, TAX, NOA, HBP, PSTG, Reduced Positions: EHTH, BEAT, RNET, SIEN, PCOM, PGTI, YUME, KIN, SD, SREV, Sold Out: NAME, BLBD, AIQ, CARB, QNST, IVTY, RM, VRTS, UNAM, COVS,

For the details of CANNELL CAPITAL LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=CANNELL+CAPITAL+LLC

Hot High Tech Stocks To Buy For 2019: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

Hot High Tech Stocks To Buy For 2019: Liquor Stores N.A. Ltd. (LQSIF)

Advisors’ Opinion:

  • [By ]

    It also holds just under 20 percent share of Liquor Stores N.A. (OTCPK:LQSIF) and over 17 percent of Radient Technologies Inc. (OTC:RDDTF). Aurora has other holdings as well.

Hot High Tech Stocks To Buy For 2019: Penumbra, Inc.(PEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Penumbra (NYSE:PEN) released its quarterly earnings results on Tuesday. The company reported $0.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.08, Fidelity Earnings reports. Penumbra had a return on equity of 1.15% and a net margin of 3.65%. The business had revenue of $102.70 million for the quarter, compared to analysts’ expectations of $90.98 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The company’s revenue was up 40.3% compared to the same quarter last year.

Hot High Tech Stocks To Buy For 2019: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Francesca’s Holdings Corp. (NASDAQ: FRAN) dropped about 4.5% Monday to post a 52-week low of $5.68 after closing at $5.95 on Friday. The 52-week high is $19.50. Volume was around 2.7 million, more than double the daily average. The specialty retailer lowered its fourth-quarter outlook last Friday and the investor walkaway continues.

  • [By Paul Ausick]

    Francesca’s Holdings Corp. (NASDAQ: FRAN) dropped about 21% Friday to post a 52-week low of $5.95 after closing at $7.50 on Thursday. The 52-week high is $19.50. Volume was around 7.8 million, about 7 times the daily average. The specialty retailer lowered its fourth-quarter outlook and investors did not respond well.

Hot High Tech Stocks To Buy For 2019: Layne Christensen Company(LAYN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Layne Christensen (NASDAQ:LAYN) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Layne Christensen earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave media coverage about the construction company an impact score of 45.8722865003839 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Hot High Tech Stocks To Buy For 2019: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

Top 10 Blue Chip Stocks To Buy Right Now

The major indexes rose to new highs this week as investorsignored the chaos in Washington and refused to let the market fall.

Getty Images

The S&P 500 rose 1.5% this week after advancing 0.2% to 2,351.16 today, while the Dow Jones Industrial Average gained 1.7% this week after ticking up 4.28 points to 20,624.05. The Nasdaq Composite climbed 1.8% this week after today.

There were all sorts of reasons for the market to drop this week: Fed chief Janet Yellen was more hawkish than expected when she testified to Congress this week, while President Donald J. Trump was busy defending himself, rather than proposing business friendly legislation.

But the market refused to take a loss for an answer. Today, for instance, the Dow had been down as much as 87.16 points, before rallying back, while the blue chip benchmark rallied back from a 55.03 decline. In fact, that’s been the pattern all year in the S&P 500, explains the folks at Bespoke Investment Group:

Top 10 Blue Chip Stocks To Buy Right Now: SunTrust Banks, Inc.(STI)

Advisors’ Opinion:

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Motley Fool Staff]

    It seems like we’re hearing about new data breaches on a regular basis, and SunTrust’s (NYSE:STI) recent one affecting 1.5 million customers could seem alarming. Here’s what investors — and consumers — need to know about it and how this one is different from some of the other high-profile data breaches we’ve heard about.

  • [By Matthew Frankel]

    Michael Douglass:Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.It’sMonday, April 23rd,and we have a round-up of financials news: yetanother Wells Fargofine, Morgan Stanley(NYSE:MS) and Goldman Sachs(NYSE:GS) earnings, and a data breach atSunTrust (NYSE:STI). I’m your host,Michael Douglass, and I’m joined by Matt Frankel. Matt,welcome back! Let’s hop right in,because really, quite a bit of interesting newsfor us to talk about today. First off,Wells Fargo was fined $1 billion from theConsumer Financial Protection Bureau.

Top 10 Blue Chip Stocks To Buy Right Now: Umicore S.A. (UMICF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other major cobalt miners (note their focus is mostly on copper and nickel or other commodities) include Eurasian Resources Group (private), Umicore SA (OTCPK:UMICF), Lundin Mining (TSX:LUN) (OTCPK:LUNMF), MMC Norilsk Nickel (OTCPK:NILSY) (LSX:MNOD), Vale S.A. (NYSE:VALE), BHP (NYSE:BHP), Jinchuan Group International Resources Co Ltd (HK:2362).

Top 10 Blue Chip Stocks To Buy Right Now: Warren Resources Inc.(WRES)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Warren Resources, Inc. (NASDAQ: WRES) were down 31 percent to $0.0656. Warren Resources filed for Chapter 11 bankruptcy.

    Gogo Inc (NASDAQ: GOGO) was down, falling around 15 percent to $9.40 after the company announced it has reached an agreement with American Airlines Group Inc (NASDAQ: AAL) to “continue to provide service on a meaningful portion of the American fleet currently served by Gogo.” Investors heavily sold off the stock as the company’s announcement implies it lost some orders to its main competitor, ViaSat, Inc. (NASDAQ: VSAT).

Top 10 Blue Chip Stocks To Buy Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Top 10 Blue Chip Stocks To Buy Right Now: Wolverine World Wide, Inc.(WWW)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Matt Hogan]

    SKX is also highly attractive in a relative basis when compared to several of its publicly traded peers: Foot Locker, Inc. (NYSE: FL), Deckers Outdoor Group (NYSE: DECK), Wolverine World Wide, Inc. (NYSE: WWW) and Columbia Sportswear Company (NASDAQ: COLM). The company's forward EBITDA multiple of 6.9x is equal or below all of the comparable companies: FL (6.9x), DECK (7.6x), WWW (10.1x) and COLM (10.8x).

  • [By Stephan Byrd]

    Wolverine World Wide (NYSE:WWW)‘s stock had its “neutral” rating restated by Buckingham Research in a research note issued to investors on Wednesday. They currently have a $32.00 target price on the textile maker’s stock. Buckingham Research’s target price would indicate a potential upside of 5.51% from the company’s current price.

Top 10 Blue Chip Stocks To Buy Right Now: GRAVITY Co. Ltd.(GRVY)

Advisors’ Opinion:

  • [By Cooper Creagan]

    For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.

  • [By Lisa Levin]

    Gravity Co., LTD. (ADR) (NASDAQ: GRVY) shares shot up 111 percent to $9.61 after the company reported Q3 results. GRAVITY reported Q3 earnings of $0.74 per share on sales of $13.143 million.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.

  • [By Peter Graham]

    While small cap gaming stocks Gravity Co. LTD (NASDAQ: GRVY), Inspired Entertainment (NASDAQ: INSE) and SPYR Inc (OTCQB: SPYR) may not be well know to investors, their games are well known to gamers.

  • [By Lisa Levin]

    Shares of Gravity Co., LTD. (ADR) (NASDAQ: GRVY) were down 13 percent to $49.03 following Q3 results. Gravity posted Q3 earnings of $0.34 per share on sales of $20.76 million.

Top 10 Blue Chip Stocks To Buy Right Now: Sotheby's(BID)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Travis Hoium]

    Shares of auction house Sotheby’s (NYSE:BID) jumped as much as 14.7% in trading Monday after the company released fourth-quarter results. And shares kept steaming, trading 13.6% higher as of 12:30 p.m. EST.

  • [By Lisa Levin]

    Sothebys (NYSE: BID) reported better-than-expected results for its fourth quarter on Monday.

    Sothebys posted quarterly adjusted earnings of $1.35 per share on revenue of $308.69 million. Analysts were expecting earnings of $1.17 per share on revenue of $277.28 million.

  • [By Ben Levisohn]

    Sotheby’s (BID) has climbed 5.3% to $34 after the auction house’s earnings and revenue topped Street estimates.

    Tyson Foods (TSN) has gained 3.5% to $76.20 after beating earnings forecasts and raising its full-year guidance.

  • [By Marshall Hargrave]

    Now Loeb's looking to put that capital to work in other markets, with the art market being a perfect candidate. Loeb and his Third Point hedge fund have started their latest activist campaign with leading auction house Sotheby's (NYSE: BID). Loeb joins fellow activist investor Marcato Capital in the stock.

Top 10 Blue Chip Stocks To Buy Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

Top 10 Blue Chip Stocks To Buy Right Now: GAIN Capital Holdings, Inc.(GCAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.16 percent. Meanwhile, top losers in the sector included Federated National Holding Co (NASDAQ: FNHC), down 11 percent, and Gain Capital Holdings Inc (NYSE: GCAP), down 7 percent.

Top 10 Blue Chip Stocks To Buy Right Now: Bavarian Nordic A/S (BVNKF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Leuven, Belgium-based Tigenix (OTC:TGXSF) filed to go public in the U.S. in late 2015, only to become entangled with Bavarian Nordic (OTC:BVNKF) and Basilea Pharmaceutica (OTC:BPMUF) as the European drugmakers pulled back from NASDAQ. Tigenix subsequently increased its bank account following a 23.75 million placement in Belgium, and added an additional 25 million via a relationship with Takeda, before coming back to Wall Street in October 2016 with a revamped slate of underwriters.

Best Biotech Stocks To Invest In Right Now

Its time for the final push.

With only a handful of trading weeks remaining in 2017, little stands in the way of higher prices.

This years stock market melt-up has produced a long list of incredible winners. The FAANGs, semiconductors, and other big tech stocks have helped fuel the rally. Weve also had multiple chances to profit from the big biotech comeback and the rebirth of homebuilder stocks two more powerful market stories that have led to impressive gains this year.

Many of these stocks will continue to sneak higher during the holiday season. Once again, this rally rewards patient traders and investors who arent afraid to ride the markets most powerful trends.

But theres one group of stocks flying under the radar as melt-up season accelerates…

Unfortunately, many investors have a bad habit of ignoring some of the markets strongest plays simply because they dont know much about the companies responsible for the gains. Theyre caught up in the big narratives the media pipes into our skulls every day.

Best Biotech Stocks To Invest In Right Now: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Proteon Therapeutics Inc (NASDAQ: PRTO) got a boost, shooting up 31 percent to $1.70 after the company disclosed that it has received the FDA Breakthrough Therapy designation for Vonapanitase. Proteon Therapeutics posted a narrower-than-expected quarterly loss.

Best Biotech Stocks To Invest In Right Now: Opexa Therapeutics, Inc.(OPXA)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Opexa Therapeutics Inc (NASDAQ: OPXA) and Acer Therapeutics announced a merger that will result in 11.2-percent ownership by current Opexa shareholders and 88.8-percent ownership by current Acer shareholders.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares were also up, gaining 66 percent to $1.08 after the company announced plans to acquire Acer Therapeutics.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares dropped 70 percent to $1.02 after the company disclosed that its top-line results from Phase 2b Abili-T trial evaluating Tcelna did not meet primary endpoint.

Best Biotech Stocks To Invest In Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Top 10 Blue Chip Stocks To Own Right Now

May 23, 2017: Markets opened higher again Tuesday but have not moved much higher as the session went on. The blue chips performed best with particular strength in financials. Tech stocks and consumer discretionaries are on track for a down finish. WTI crude oil for July delivery settled at $51.47 a barrel, up 0.7%. June gold dipped 0.5% for the day to settle at $1,255.60. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.16% for the day, the S&P 500 traded up 0.14%, and the Nasdaq Composite traded down 0.01%.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was The Goldman Sachs Group Inc. (NYSE: GS) which traded up 1.75% at $219.80. The stock’s 52-week range is $138.20 to $3255.15. Volume was about 30% below the daily average of around 3.7 million shares. The company had no specific news Monday.

JPMorgan Chase & Co. (NYSE: JPM) traded up 1.28% at $85.78. The stock’s 52-week range is $57.05 to $93.98. Volume was about 40% below the daily average of around 14.8 million shares. The big bank had no specific news.

Top 10 Blue Chip Stocks To Own Right Now: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap insurance software stock Ebix Inc (NASDAQ: EBIX) reported Q1 2017 earnings before the market opened this morning. Q1 revenue rose 11% to $79.1 million and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Companys Exchange, Risk Compliance, and Broker Solution channels. On a constant currency basis, Q1 revenue increased 10% to $78.5 millionwith theExchange channel continued to bethe Companyslargest -accounting for 67% of Q1 2017 revenues. Q1 2017 net income rose 19% to $26.4 million with the improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.

Top 10 Blue Chip Stocks To Own Right Now: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Leo Sun]

    In a previous article, I reviewed why GoPro, Twilio, and Wuba.com were all cut in half in 2016. Today I’ll add two Chinese tech stocks to that list — Renren (NYSE:RENN) and 21Vianet (NASDAQ:VNET) — which both lost more than half their value over the past 12 months.

  • [By Monica Gerson]

    21Vianet Group Inc (NASDAQ: VNET) shares rose 5.88 percent to $15.30 in the pre-market trading session as the company reported a $388 million investment by TUS Holdings.

Top 10 Blue Chip Stocks To Own Right Now: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Vanguard's latest fee cuts answer two such moves this year, including one this month, by rival BlackRock, Inc. (NYSE: BLK) and one fee reduction announcement by Charles Schwab Corp (NYSE: SCHW).

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) also had a famous investor selling stock this past week. The chairman of the company, Charles Schwab, continues to sell stock at an orderly pace. This week the iconic discount brokerage executive and the CEO of the company combined to sell a block of 400,000 shares at prices between $35.43 and $35.46. The total for the trades came to a whopping $14 million.As we have noted in the past, Mr. Schwab is past 80 years old, and clearly much of his selling over the years has been for estate planning purposes. The shares endedFriday at $37.48 so a fair amount left on the table.

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) had a famous investor selling stock this past week. Chairman Charles Schwab continues to sell stock at an orderly pace. This week the iconic discount brokerage executive sold 600,000 shares at prices between $32.50 and $33.75. The total for the trade came to a whopping $20 million.As we have noted in the past, Schwab is past 80 years old and clearly much of his selling over the years has been for estate planning purposes. The shares traded Friday at $35.25, so a fair amount left on the table.

  • [By Tyler Crowe, Tim Brugger, and Jordan Wathen]

    With that in mind, we asked three of our contributors to highlight a company they will be following closely in the first quarter and why. Here’s what makes Adobe Systems (NASDAQ:ADBE), Charles Schwab (NYSE:SCHW), and U.S. Silica Holdings (NYSE:SLCA) worth following when the next earnings report comes out.

  • [By ]

    Darn hard to not like the numbers out of Action Alerts PLUS holding JPMorgan & Chase (JPM) . Profits up nicely in all segments vs. the fourth quarter. Big year-over-year spikes in return on assets and equity from a year ago. Trading revenue up thanks to the return of volatility in the first quarter (can’t wait to see the blowout quarters from TD Ameritrade (AMTD) and Schwab (SCHW) ). Good card revenue growth from the fourth-quarter bodes well for retailer’s first-quarter results.

Top 10 Blue Chip Stocks To Own Right Now: Biotricity (BTCY)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Peter Graham]

    On the other hand, small cap wearables stock Biotricity (OTCQB: BTCY)is a different wearables play as theCompanys mission is to revolutionize chronic care management by developing innovative solutions that bridge the gap between diagnostic care and disease management. A medical technology company, Biotricity is focused on delivering innovative, remote biometric monitoring solutions to the healthcare and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricitys R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The Company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system.

Top 10 Blue Chip Stocks To Own Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

Top 10 Blue Chip Stocks To Own Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Top 10 Blue Chip Stocks To Own Right Now: Glaukos Corporation(GKOS)

Advisors’ Opinion:

  • [By Nelson Hem]

    In "Skeptics Eye Potential Trouble for Glaukos," Vito J. Racanelli suggests that, even though Glaukos Corp (NYSE: GKOS) has warned that it might lose money this year, Wall Street appears to be betting otherwise. This eye-stent maker has had success with a breakthrough product and dominates its market, but formidable competition still looms.

Top 10 Blue Chip Stocks To Own Right Now: Zillow Group, Inc.(ZG)

Advisors’ Opinion:

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

Top 10 Blue Chip Stocks To Own Right Now: Varex Imaging Corporation (VREX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Varex Imaging (VREX), a stock that wasn’t even in the index yesterday, soared to the top of the S&P 500 today after being spun out of Varian Medical Systems (VAR).

    Agence France-Presse/Getty Images

    Varex Imaging gained 7.3% to $27.27 today, while the S&P 500 declined 0.6% to2,280.90. Varian Medical Systems fell 1.2% to $77.68.

    Varian Medical Systems reported net income of $402 million on sales of $3.2 billion in 2016.

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

Top 10 Blue Chip Stocks To Own Right Now: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    The mall was created by accident, in some ways. Downtown Bloomington, Minnesota, lost its two largest corporate residents in 1982, football’s Minnesota Vikings and baseball’s Minnesota Twins. Over 78 acres became available for development. After debates about what should happen to the land, local officials decided to give it to financiers who wanted to build America’s largest home for retailers. It opened in 1992, two years before Amazon.com Inc. (NASDAQ: AMZN) was founded. Early tenants included Macy’s Inc. (NYSE: M), the Sears division of Sears Holdings Corp. (NASDAQ: SHLD) and Nordstrom Inc. (NYSE: JWN). All three have been injured by the current downturn in traditional retail sales.

  • [By ]

    Some reasons for my bearishness on retail stocks:

    Higher Energy Prices. Oil prices have rallied dramatically and back to 2014 levels, rising from about $35 a barrel in early 2016 to around $67 Thursday. That’s bad news for U.S. retailers, as rising oil prices historically squeeze consumer disposable incomes. That’s one reason why I’ve been consistently raising my short exposure to retail and plan to continue doing so. Shaky Same-Store Sales Growth. Recent improvements to same-store sales at Abercrombie & Fitch (ANF) , Urban Outfitters (URBN) , Dillard’s (DDS) , Gap Inc. (GPS) and Macy’s (M) come against downgraded expectations, and might not be sustainable anyway. No Deal for Nordstrom (JWN) . The Nordstrom family has apparently abandoned plans to take its namesake company private. I had expressed concerns that this would happen. Higher Interest Rates. A rise in the London Inter-Bank Offered Rate (LIBOR) has recently accelerated. That’s bad news for retailers, as many variable-rate consumer debts (particularly mortgages) key off of the LIBOR. This will likely put a damper on mortgage refinancings — something that many see as an important ingredient for personal-consumption expenditures.

  • [By Rich Duprey]

    An increasing number of retailers have announced their intention to drop Ivanka Trump’s merchandise line. From Nordstrom (NYSE:JWN) and Belk to Neiman-Marcus and Burlington, there’s a growing movement for retailers to distance themselves from the Trump brand.

  • [By Chris Lange]

    Look for Nordstrom Inc. (NYSE: JWN) to reveal its fiscal second-quarter results on Thursday as well. The consensus analyst estimates are $0.63 in EPS and revenue of $3.74 billion. Shares of Nordstrom closed at $46.81 on Friday, above the consensus price target of $46.00. The 52-week range is $39.53 to $62.82.

Top 5 Clean Energy Stocks To Invest In Right Now

One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.

Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.

Li, who’s estimated to be worth around $18 billion, has said he’s not interested in a takeover of Daimler. It’s unclear exactly what he’s after with such a big investment, but he dropped a big hint that the German company’s engineering is central to his vision.

“In order to succeed and seize the technology highland, one has to have friends, partners, and alliances and adapt a new way of thinking in terms of sharing and united strength,” Li said in a statement over the weekend.

Some analysts suggest Li wants to get his hands on Daimler’s clean energy technology. That could help boost Geely’s competitive position in China’s market for electric vehicles, which is already the world’s biggest.

Top 5 Clean Energy Stocks To Invest In Right Now: Armstrong World Industries Inc(AWI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

Top 5 Clean Energy Stocks To Invest In Right Now: Aon Corporation(AON)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    We’re seeing the exact same price pattern playing out in shares of $29 billion risk and insurance consultancy firm Aon plc (AON) . Aon has been a strong performer for all of 2016, up 20% since the calendar flipped to January. But don’t worry if you’ve missed the move – an ascending triangle pattern is signaling a second leg higher here. For Aon, the breakout level to watch is resistance up at $113.

Top 5 Clean Energy Stocks To Invest In Right Now: OncoMed Pharmaceuticals, Inc.(OMED)

Advisors’ Opinion:

  • [By Paul Ausick]

    OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped nearly 44% Monday to post a new 52-week low of $4.94 after closing Friday at $8.76. The stock’s 52-week high is $15.49. Volume of about 3.3 million shares was nearly 20 times the daily average of around 182,000. A proposed deal with Bayer AG fell through and one of the company’s drugs failed a phase 2 clinical trial.

  • [By Paul Ausick]

    OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped about 5.3% Wednesday to post a new 52-week low of $4.69 after closing at $4.95 on Tuesday. The stock’s 52-week high is $15.49. Volume was more than double the daily average of around 270,000 shares. The company had no specific news Wednesday.

  • [By Teresa Rivas]

    OncoMed Pharmaceuticals (OMED) has lost more than a third of its value Monday, after Bayer decided not to exercise its option to license the firms Phase II-ready WNT pathway inhibitors Vantictumab and Ipafricept, which treat pancreatic cancer.

    Pixabay

    That wasnt the only bad news, however, as the firms randomized-controlled Phase II “YOSEMITE” trial of pancreatic cancer drug demcizumab also missed its primary endpoint.

    Leerinks Michael Schmidt and his team reiterated a Market Perform rating on the stock Monday, and lowered their price target from $10 to $6 on the news, calling it a “double setback” for OncoMed.

    More detail from the note:

    This is a major setback for OMED and in our view for the cancer stem cell targets more broadly, which have been a difficult area of drug development. We’ve been cautious on the probability-of-success of these agents and see more promise on OMED’s recent efforts in building a second area of focus in immuno-oncology. Going forward, OMED plans to review and prioritize its R&D pipeline after results from the still pending tarextumab Phase II “PINNACLE” trial in small cell lung cancer (SCLC) and data from the demcizumab “DENALI” trial in NSCLC are available in 2Q17. We remain MP rated in light of the uncertainties around OMED’s pipeline and strategy at this point. We previously assigned a 30% probability of success (POS) to demcizumab which we now have removed from our model. We also think chances that CELG will opt-into this program are slim and we have removed associated POS-adjusted milestone payments from our model. OMED has cash to run operations through 3Q18.

    OncoMed is down 36.1% to $5.60 this afternoon.

Top 5 Clean Energy Stocks To Invest In Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Top 5 Clean Energy Stocks To Invest In Right Now: G&K Services, Inc.(GK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cintas (CTAS) soared to the top of the S&P 500 today after the uniform provider received the go-ahead for its purchase of G&K Services (GK).

  • [By Ben Levisohn]

    We maintain our positive view toward Cintas, particularly as G&K Services (GK) is likely to bolster Cintas’s growth potential over the next few years. However, after strong appreciation since the G&K announcement last August, we believe that much of the good news is already priced in at 25x/22x our pro-forma FY18/FY19 adjusted EPS estimates. As a result, we rate CTAS Sector Perform and await a better entry point.

Best Casino Stocks To Invest In 2018

Allegations that casino mogul Steve Wynn sexually harassed numerous employees at his Las Vegas resort may tilt the scales at the upcoming trial with his ex-wife, who claims she was booted off the company’s board for challenging his “reckless behavior."

“It’s a game changer," said Devin McRae, a litigator with Early Sullivan Wright Gizer & McRae in Los Angeles. “These allegations paint a picture of serious predation."

#lazy-img-323091068:before{padding-top:69.81818181818181%;}Elaine Wynn.Photographer: Gabe Ginsberg/Getty Images

Elaine Wynn, who has been fighting her ex-husband to gain control over her $1.8 billion stake in Wynn Resorts Ltd., claims she lost her board seat in 2015 because she raised questions about how Steve ran the company, including hiding from the board that he paid millions of dollars to settle misconduct claims by a former employee. Steve Wynn has denied the harassment allegations that were reported Friday by the Wall Street Journal.

Best Casino Stocks To Invest In 2018: Laredo Petroleum, Inc.(LPI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After a rally for the ages, the price of oil is back over $50. But the biggest threat to oil might be more production from exploration & production companies drilling in the U.S. shale, say Credit Suisse analyst Mark Lear and team, who cut their ratings on Carrizo Oil & Gas (CRZO), Laredo Petroleum (LPI) and Sanchez Energy (SN). They explain why:

Best Casino Stocks To Invest In 2018: Sirius XM Radio Inc.(SIRI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Pandora Mediapeaking in 2014 before heading back to where it started while other streaming media stocks such as large cap satellite radio stockSirius XM Radio Inc (NASDAQ: SIRI) has performed better and InternetTV stock Netflix, Inc (NASDAQ: NFLX) has been a homerun:

  • [By Rick Munarriz]

    There are a lot of people betting against Sirius XM Radio (NASDAQ:SIRI)these days, even as the stock is hitting 10-year highs. There were 280.1 million shares of Sirius XM sold short at the end of 2016, just below the late-November peak of 285.1 million shares but nearly double the short interest that we were seeing a year ago.

  • [By Jon C. Ogg]

    The long saga regarding Pandora Media Inc. (NYSE: P) has finally come to a head. Well, maybe. Rather than KKR & Co. L.P. (NYSE: KKR) investing $150 million, Sirius XM Holdings Inc. (NASDAQ: SIRI) will be investing up to $480 million in the streaming music rival. With its ticketing unit sale taking place as well, it might seem that Pandora is getting a great deal and helping to bolster its books.

  • [By Jon C. Ogg]

    Sirius XM Holdings Inc. (NASDAQ: SIRI) is a company that thrives on of new car sales. If you have had satellite radio and are not solely reliant on what you get for music in streaming or your library, then chances are pretty good that you won’t want to go back to just having old-fashioned FM/AM radio.

  • [By ]

    However, several Buffett stocks chalked up nice gains during the first quarter. The three top performers in Berkshire’s portfolio were Sirius XM Holdings (NASDAQ:SIRI), Mastercard (NYSE:MA), and Moody’s (NYSE:MCO). Here’s what drove these stocks higher — and what their prospects are for the rest of 2018.

Best Casino Stocks To Invest In 2018: ONEOK Partners L.P.(OKS)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By Garrett Cook]

    Citi maintains Buy ratings on Targa Resources (NYSE: TRGP), ONEOK (NYSE: OKE) and Oneok Partners (NYSE: OKS) citing the companies stories around natural gas liquids (NGLs).

Best Casino Stocks To Invest In 2018: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Best Casino Stocks To Invest In 2018: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Preferred Bank (PFBC) has surged 54% in the past year but still trades at a modest discount to the median S&P 1500 regional bank, based on both trailing earnings and estimated 2017 profits.